期刊文献+

吡贝地尔的合成工艺研究 被引量:4

Improved synthesis of piribedil
原文传递
导出
摘要 目的改进吡贝地尔的合成工艺。方法以邻苯二酚和二氯甲烷为原料经环和反应合成胡椒环,胡椒环与多聚甲醛经Blanc氯甲基化反应合成重要中间体胡椒基氯(3);以哌嗪和二氯嘧啶为原料经氮烷基化反应合成重要中间体1-(2-嘧啶基)哌嗪(4);3和4经氮烷基化反应得到目标化合物。结果与结论目标化合物的结构经1H-NMR、GC-MS谱确证,总收率为44.2%,改进后的工艺操作简便,成本低廉,有利于工业化生产。 Aim To improve the procedure of piribedil.Methods The intermediate piperonyl chloride(3) was obtained through cyclization and Blanc reaction by using o-dihydroxybenzene and dichloromethane as starting material.Another intermediate 1-(2-pyrimidyl)piperazine(4) was obtained through N-alkylation by using 2-chloropyrimidine and piperazine as starting material.After N-alkylation between intermediates(3) and(4),piribedil could be obtained.Results and conclusion The structure of piribedil was confirmed by 1H-NMR,GC-MS.The overall yield is 44.2%.The improved process has the advantage of low cost and it is also suitable for industrial production.
出处 《中国药物化学杂志》 CAS CSCD 2010年第4期285-286,297,共3页 Chinese Journal of Medicinal Chemistry
关键词 吡贝地尔 多巴胺能激动剂 帕金森病 工艺改进 piribedil dopaminergic agonist Parkinson′s disease process improvement
  • 相关文献

参考文献10

  • 1闫卫红,程焱.吡贝地尔治疗帕金森病的临床研究[J].中西医结合心脑血管病杂志,2005,3(10):853-855. 被引量:10
  • 2程言博,钱进军,毛成洁,刘康永,刘春风.吡贝地尔对早期帕金森病非运动症状的影响[J].中国临床神经科学,2007,15(2):119-122. 被引量:8
  • 3LEBRUN F C, BORG M. Choosing the right dopamine agonist for patients with Parkinson's disease [ J ]. Curt Med Res Opin,2002,18 ( 4 ) : 209 - 214.
  • 4康彦龙.一种吡贝地尔的制备方法:CN,200510077342.4[P].2006-12-27.
  • 5REGNIER G L, CANEVARI R G. Synthesis and vasodilator activity of new piperazine derivatives [J].J Med Chem,1968,11 (6) :1151 -1155.
  • 6GIBERT R, MICHEL L, ROGER C, et al. 2-[ 1'- ( Benzyl and phenyl ) -4'-piperazinyl ]-pyrimidine derivatives : US ,3299067 [ P]. 1967 - 01 - 17.
  • 7李鑫,赵士举,吴娟,苏惠,陈见.1,2-亚甲二氧基苯的合成工艺研究[J].科技导报,2007,25(15):40-43. 被引量:3
  • 8董新荣,李辉,杨建奎,李霞,李宇.3,4-亚甲二氧基苯酚的合成[J].精细化工中间体,2006,36(1):60-62. 被引量:11
  • 9ZHANG W G, LIN J G, NIU Z Y, et al. Total synthesis of two new dihydrostilbenes from Bulbophyllum odoratissimum [ J ]. J Asian Nat Prod Res, 2007, 9(1) :23 -28.
  • 10HOWARD K L, STEWART H W, CONROY E A, et al. Piperazines. Ⅱ. 1-Heterocyclicpiperazines and 1-heterocyclic-4-carboethoxypiperazines [ J ]. J Org Chem, 1953,18 ( 11 ) : 1484 - 1488.

二级参考文献43

  • 1董新荣,李辉,杨建奎,李霞,李宇.胡椒环的合成[J].化工技术与开发,2006,35(1):7-9. 被引量:9
  • 2董新荣,李辉,杨建奎,李霞,李宇.3,4-亚甲二氧基苯酚的合成[J].精细化工中间体,2006,36(1):60-62. 被引量:11
  • 3汪向东.心理卫生评定量表手册[J].中国心理卫生杂志,1993,:202-209.
  • 4Corrodi H, Fuxe K, Ungersted U. Evidence for a new type of dopamine receptor stimulating agent[J]. J Pharm Pharmacol, 1971,23: 989 - 991.
  • 5Smith LA, Jackson MG, Bonhomme C, et al. Transdermal administration of piribedil reverses MPTP - induced motor deficits in the common marmoset [J ]. Clin Neuropharm, 2000,23:133 - 142.
  • 6Rondot P, Ziegler M. Activity and acceptability of piribedil in Parkinson's disease: A multicenter study [J]. J Neurol, 1992,239 ( 1 ): S28 -S34.
  • 7Mentenopolous G, Katsarou Z, Bostantjopoulou S, et al. Piribedil therapy in Parkinson's disease [J]. Clin Neuropharm, 1989,12: 23 - 28.
  • 8Ziegler M, Castro CA, Del SS, et al. Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease:A 6 - month, randomized, placebo - controlled study [J]. Mov Disord,2003,18:418 - 425.
  • 9Joehn GN,Juhr PH, Stephen TG. Parkinson's disease( 100 Maxims)[J]. London: Edwanl Arndd, 1992:74 - 75.
  • 10王新德.金森病及帕金森综合征的诊断标准和鉴别诊断[J].中华神经精神科杂志,1985,18(4):255-255.

共引文献24

同被引文献15

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部